Goldan Keith A. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Goldan Keith A.（CIK 1495411）在 2 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-06-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-02 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 卖出 | 1,177 | $22,351 |
| 2026-04-07 | ABEONA THERAPEUTICS INC. (ABEO) | 董事 | 买入 | 32,751 | $0 |
| 2026-02-10 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 卖出 | 3,410 | $71,712 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 买入 | 1,219 | $10,337 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 买入 | 21,500 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 买入 | 30,750 | $0 |
| 2026-02-06 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 卖出 | 2,082 | $42,931 |
| 2025-12-01 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 卖出 | 1,224 | $0 |
| 2025-08-07 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 买入 | 1,226 | $10,335 |
| 2025-07-18 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 卖出 | 1,296 | $12,040 |
| 2025-05-19 | Syndax Pharmaceuticals Inc (SNDX) | Chief Financial Officer | 买入 | 3,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-02